Nicolas Vigneron

Publications

Article dans une revue (11)

Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study Jonaz Font,Amir Hodzic,Angélique Da-Silva,Baptiste Delapierre,Ghandi Damajet al. Biomedicines, 2025, 13 (9), pp.2184. ⟨10.3390/biomedicines13092184⟩ Article dans une revue hal-05411085v1
Epidemiological Classification Changes and Incidence of Early-Onset Colorectal Cancer Valérie Jooste,Jean-Baptiste Nousbaum,Arnaud Alves,Anne-Sophie Woronoff,Guy Launoyet al. JAMA Network Open, 2025, 8 (11), pp.e2541732. ⟨10.1001/jamanetworkopen.2025.41732⟩ Article dans une revue hal-05419503v1
Geographical variability in cancer incidence explained by the socioeconomic environment: an example of lung cancer in northwestern France Pauline Pouchin,Michaël Genin,Simona Bara,Nicolas Vigneron,Guy Launoyet al. Journal of Epidemiology and Community Health, 2025, 79 (3), pp.200-206. ⟨10.1136/jech-2024-222704⟩ Article dans une revue hal-05419547v1
Is Survival Impacted by One or Several Successive Cancers After Liver Transplantation? A French National Study Anaïs Briant,Rémy Morello,Olivier Sérée,Nicolas Vigneron,Sarah Wilsonet al. Clinical Transplantation, 2025, 39 (2), pp.e70109. ⟨10.1111/ctr.70109⟩ Article dans une revue hal-05411064v1
More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: a French population-based study from Francim network of cancer registries Sébastien Lamy,Valérie Jooste,Cyrille Delpierre,Karima Hammas,Nicolas Vigneronet al. The French Journal of Urology, 2025, 36 (1), pp.103066. ⟨10.1016/j.fjurol.2025.103066⟩ Article dans une revue hal-05413812v1
Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries Joséphine Gardy,Sarah Wilson,Anne‐valérie Guizard,Véronique Bouvier,Ludivine Launayet al. Cancer, 2024, 130 (23), pp.4096-4108. ⟨10.1002/cncr.35519⟩ Article dans une revue hal-05419555v1
Geographical variability in cancer incidence explained by the socioeconomic environment: an example of lung cancer in northwestern France Pauline Pouchin,Michaël Genin,Simona Bara,Nicolas Vigneron,Guy Launoyet al. Journal of Epidemiology and Community Health, 2024, 79 (3), pp.200 - 206. ⟨10.1136/jech-2024-222704⟩ Article dans une revue hal-05411561v1
The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels Anaïs Wambecke,Mohammad Ahmad,Pierre‐marie Morice,Bernard Lambert,Louis‐bastien Weiswaldet al. Molecular Oncology, 2021, Mol Oncol, 15 (12), pp.3659-3678. ⟨10.1002/1878-0261.13045⟩ Article dans une revue inserm-05418234v1
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects Matthieu Meryet-Figuiere,Mégane Vernon,Mamy Andrianteranagna,Bernard Lambert,Célia Brochenet al. Cancers, 2021, 13 (16), pp.3970. ⟨10.3390/cancers13163970⟩ Article dans une revue hal-05418298v1
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids Mégane Vernon,Bernard Lambert,Matthieu Meryet-Figuière,Emilie Brotin,Louis-Bastien Weiswaldet al. Molecular Cancer Therapeutics, 2020, 19 (7), pp.1506-1519. ⟨10.1158/1535-7163.MCT-19-0510⟩ Article dans une revue hal-05411088v1
Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route Matthieu Meryet-Figuière,Charlotte Lecerf,Emilie Varin,Jean-Luc Coll,Marie-Hélène Louiset al. Oncology Reports, 2017, 38 (4), pp.1949 - 1958. ⟨10.3892/or.2017.5882⟩ Article dans une revue inserm-01856064v1